A novel nanofibre shot that helps break up, as well as reverse the arterial plaque could one day be used to treat atherosclerosis, reveals a new study led by a researcher of Indian-origin.
Atherosclerosis is characterised by a narrowing of arteries and blood vessels caused by a build-up of a hard, waxy substance called plaque, which is rich in cholesterol.
Atherosclerosis
Atherosclerosis is a condition in which the arteries become hard and narrow, leading to restricted blood flow.
Advertisement
‘A single shot of synthetically designed nanofibres might one day help break up as well as reverse the arterial plaque - making this a hallmark in atherosclerosis treatment, finds a new study.’
Tweet it Now
Targeting the vessel wall with peptide-based nanofibres developed in the laboratory can non-invasively and non-surgically, halt and reverse the disease, the researchers said.
The results "demonstrate that a novel targeted nanofibre binds specifically to atherosclerotic lesions and reduces plaque burden after a short treatment duration," said lead author Neel A. Mansukhani, an integrated vascular surgery fellow at Northwestern University in Chicago, US.
![Weight Loss Therapy for Atherosclerosis Management]( "Weight Loss Therapy for Atherosclerosis Management")
Weight loss and losing fat can help in controlling atherosclerosis. Therefore, research suggests overweight and obese people to enroll in weight loss programs.
The findings were presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2018 in San Francisco.
The tiny fibres contained an amino acid sequence that promotes the cholesterol to dissolve and helped remove deposits from the plaque in the artery walls.
To test the noninvasive therapy, mice were genetically modified to rapidly develop atherosclerosis, then fed high fat diets for 14 weeks and after which the mice received biweekly injections of either the peptide amphile nanofibre or saline for 8 weeks.
After 8 weeks of treatment, plaque area in the arteries of the male mice was reduced by 11 per cent and in the female mice by 9 per cent.
While drugs such as statins are used to control low density lipoprotein (LDL) the so-called bad cholesterol and thus decrease "plaque burden", "but they have not been proven to reverse the disease", Mansukhani said.
Other treatment approaches include bypass surgery and stenting, but neither reverses the disease and each can cause damage to the vessel wall, he said.
However, more research is needed before this new approach can be tested in humans, he noted.
Source: IANS
Weight Loss Therapy for Atherosclerosis Management
Weight loss and losing fat can help in controlling atherosclerosis. Therefore, research suggests overweight and obese people to enroll in weight loss programs.
Advertisement
The findings were presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2018 in San Francisco.
The tiny fibres contained an amino acid sequence that promotes the cholesterol to dissolve and helped remove deposits from the plaque in the artery walls.
To test the noninvasive therapy, mice were genetically modified to rapidly develop atherosclerosis, then fed high fat diets for 14 weeks and after which the mice received biweekly injections of either the peptide amphile nanofibre or saline for 8 weeks.
After 8 weeks of treatment, plaque area in the arteries of the male mice was reduced by 11 per cent and in the female mice by 9 per cent.
While drugs such as statins are used to control low density lipoprotein (LDL) the so-called bad cholesterol and thus decrease "plaque burden", "but they have not been proven to reverse the disease", Mansukhani said.
Other treatment approaches include bypass surgery and stenting, but neither reverses the disease and each can cause damage to the vessel wall, he said.
However, more research is needed before this new approach can be tested in humans, he noted.
Source: IANS
New Ways to Prevent and Treat Atherosclerosis, Gum Disease
New findings could lead to effective preventive and therapeutic treatments in people with heart disease and/or gum disease without unwanted side effects.
Advertisement
 Marathons Not Linked to Atherosclerosis RiskStudies have linked risk of atherosclerosis in marathon runners. But a new research has found that marathon does not increase the risk of atherosclerosis. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.